• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation.

作者信息

Lindauer K, Loerting T, Liedl K R, Kroemer R T

机构信息

Department of Chemistry, Queen Mary and Westfield College, University of London, Mile End Road, London E1 4NS, UK.

出版信息

Protein Eng. 2001 Jan;14(1):27-37. doi: 10.1093/protein/14.1.27.

DOI:10.1093/protein/14.1.27
PMID:11287676
Abstract

The structure of human Janus kinase 2 (JAK2) comprising the two C-terminal domains (JH1 and JH2) was predicted by application of homology modelling techniques. JH1 and JH2 represent the tyrosine kinase and tyrosine kinase-like domains, respectively, and are crucial for function and regulation of the protein. A comparison between the structures of the two domains is made and structural differences are highlighted. Prediction of the relative orientation of JH1 and JH2 was aided by a newly developed method for the detection of correlated amino acid mutations. Analysis of the interactions between the two domains led to a model for the regulatory effect of JH2 on JH1. The predictions are consistent with available experimental data on JAK2 or related proteins and provide an explanation for inhibition of JH1 tyrosine kinase activity by the adjacent JH2 domain.

摘要

相似文献

1
Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation.
Protein Eng. 2001 Jan;14(1):27-37. doi: 10.1093/protein/14.1.27.
2
Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain.Jak2酪氨酸激酶的自抑制依赖于其假激酶结构域中的特定区域。
Mol Biol Cell. 2003 Apr;14(4):1448-59. doi: 10.1091/mbc.e02-06-0342.
3
Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7.
Protein Eng. 2002 Sep;15(9):727-37. doi: 10.1093/protein/15.9.727.
4
Structural and Functional Characterization of the JH2 Pseudokinase Domain of JAK Family Tyrosine Kinase 2 (TYK2).JAK家族酪氨酸激酶2(TYK2)的JH2假激酶结构域的结构与功能表征
J Biol Chem. 2015 Nov 6;290(45):27261-27270. doi: 10.1074/jbc.M115.672048. Epub 2015 Sep 10.
5
Evolutionary analysis for functional divergence of Jak protein kinase domains and tissue-specific genes.Jak蛋白激酶结构域与组织特异性基因功能分化的进化分析
J Mol Evol. 2002 Jun;54(6):725-33. doi: 10.1007/s00239-001-0072-3.
6
Analysis of Jak2 catalytic function by peptide microarrays: the role of the JH2 domain and V617F mutation.通过肽微阵列分析 Jak2 催化功能:JH2 结构域和 V617F 突变的作用。
PLoS One. 2011 Apr 18;6(4):e18522. doi: 10.1371/journal.pone.0018522.
7
Expression, characterization, and genomic structure of carp JAK1 kinase gene.鲤鱼JAK1激酶基因的表达、特性及基因组结构
DNA Cell Biol. 1996 Oct;15(10):827-44. doi: 10.1089/dna.1996.15.827.
8
New insights into the structure and function of the pseudokinase domain in JAK2.新型伪激酶结构域在 JAK2 中的结构与功能的深入研究。
Biochem Soc Trans. 2013 Aug;41(4):1002-7. doi: 10.1042/BST20130005.
9
Mechanisms of constitutive activation of Janus kinase 2-V617F revealed at the atomic level through molecular dynamics simulations.通过分子动力学模拟在原子水平揭示Janus激酶2-V617F组成性激活的机制。
Cancer. 2009 Apr 15;115(8):1692-700. doi: 10.1002/cncr.24183.
10
Regulation of JAK2 activation by Janus homology 2: evidence from molecular dynamics simulations.Janus 同源 2 对 JAK2 激活的调节:分子动力学模拟的证据。
J Chem Inf Model. 2012 Nov 26;52(11):2992-3000. doi: 10.1021/ci300308g. Epub 2012 Oct 18.

引用本文的文献

1
A newly identified 45-kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance.一种新鉴定的 45kDa JAK2 变体,其激酶结构域结构发生改变,代表了 JAK2 激酶抑制剂耐药的一种新机制。
Mol Oncol. 2024 Feb;18(2):415-430. doi: 10.1002/1878-0261.13566. Epub 2023 Dec 20.
2
Structural Insights into the Interaction of Heme with Protein Tyrosine Kinase JAK2*.血红素与蛋白酪氨酸激酶 JAK2*相互作用的结构研究*。
Chembiochem. 2021 Mar 2;22(5):861-864. doi: 10.1002/cbic.202000730. Epub 2020 Nov 19.
3
JAK2 and Beyond: Mutational Study of JAK2V617 in Myeloproliferative Disorders and Haematological Malignancies in Kashmiri population.
JAK2及其他:克什米尔人群骨髓增殖性疾病和血液系统恶性肿瘤中JAK2V617的突变研究
Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3611-3615. doi: 10.31557/APJCP.2019.20.12.3611.
4
Understanding the structural features of JAK2 inhibitors: a combined 3D-QSAR, DFT and molecular dynamics study.理解 JAK2 抑制剂的结构特征:三维定量构效关系、密度泛函理论和分子动力学的综合研究。
Mol Divers. 2019 Nov;23(4):845-874. doi: 10.1007/s11030-018-09913-4. Epub 2019 Jan 7.
5
Comparative study of different methodologies to detect the V617F mutation in chronic BCR-ABL1 negative myeloproliferative neoplasms.检测慢性BCR-ABL1阴性骨髓增殖性肿瘤中V617F突变的不同方法的比较研究
Pract Lab Med. 2015 Dec 14;4:30-37. doi: 10.1016/j.plabm.2015.12.004. eCollection 2016 Apr 1.
6
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions.获得性 IFNγ 抵抗会损害抗肿瘤免疫,并导致 T 细胞抵抗的黑色素瘤病变。
Nat Commun. 2017 May 31;8:15440. doi: 10.1038/ncomms15440.
7
JAK2 activation by growth hormone and other cytokines.生长激素和其他细胞因子对JAK2的激活作用。
Biochem J. 2015 Feb 15;466(1):1-11. doi: 10.1042/BJ20141293.
8
Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.聚乙二醇化脯氨酸干扰素α-2b治疗真性红细胞增多症患者的分子反应和染色体畸变
Am J Hematol. 2015 Apr;90(4):288-94. doi: 10.1002/ajh.23928. Epub 2015 Mar 2.
9
c-Abl activates janus kinase 2 in normal hematopoietic cells.c-Abl在正常造血细胞中激活Janus激酶2。
J Biol Chem. 2014 Aug 1;289(31):21463-72. doi: 10.1074/jbc.M114.554501. Epub 2014 Jun 12.
10
Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase.依赖于假激酶的 JAK2 酪氨酸激酶自身抑制的分子基础。
Nat Struct Mol Biol. 2014 Jul;21(7):579-84. doi: 10.1038/nsmb.2849. Epub 2014 Jun 11.